Related Experiment Video
Updated: May 10, 2026
Isolation of Primary Myofibroblasts from Mouse and Human Colon Tissue
Published on: October 13, 2013
Regulation of epidermal growth factor receptor in human colon cancer cell lines by interferon alpha
J-L Yang1, X-J Qu, P J Russell
1Department of Surgery, Prince of Wales Hospital, University of New South Wales, Sydney, Australia.
Background And Aim:
The biology of growth factor receptor expression has implications for receptor specific cancer therapy. In this study, we examined: (a) regulation of epidermal growth factor receptor (EGFR) expression in a panel of 10 human colon cancer cell lines using interferon alpha (IFN-alpha); (b) ability of IFN-alpha to inhibit cell proliferation; and (c) sensitivity of IFN-alpha pretreated cells to EGF.
Methods:
Cell proliferation was measured both by crystal violet colorimetric and clonogenic assays. Cell surface, intracellular, and/or total cell protein expression of EGFR was assessed by indirect immunofluorescence flow cytometry and/or fluorescein isothiocyanate (FITC)-EGF binding and internalisation flow cytometric assay.
Results:
IFN-alpha treatment upregulated expression of cell surface EGFR in seven of 10 colon cancer cell lines within 16 hours, reaching a peak within 48-96 hours; this was accompanied by transient elevation of intracellular EGFR and marked growth inhibition. IFN-alpha treated cancer cells were still sensitive to EGF proliferative stimulation.
Conclusions:
Our results indicate that cytostatic concentrations of IFN-alpha can enhance cell surface and intracellular EGFR expression in a proportion of human colon cancer cells. The antiproliferative action of IFN-alpha could not block the signal transduction of the EGF-EGFR pathway. This may have clinical implications for improving treatment based on targeting of EGFR.
Insights
Interferon alpha (IFN-alpha) increases epidermal growth factor receptor (EGFR) expression in colon cancer cells, inhibiting proliferation but not blocking EGF signaling. This has implications for EGFR-targeted cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Therapeutics
Background:
- Growth factor receptor expression is crucial for targeted cancer therapy.
- Epidermal Growth Factor Receptor (EGFR) is a key target in cancer treatment.
- Interferon alpha (IFN-alpha) is being investigated for its effects on cancer cell biology.
Purpose of the Study:
- To investigate the regulation of EGFR expression by IFN-alpha in human colon cancer cells.
- To assess the impact of IFN-alpha on colon cancer cell proliferation.
- To determine the sensitivity of IFN-alpha treated cells to EGF stimulation.
Main Methods:
- Utilized crystal violet colorimetric and clonogenic assays for cell proliferation measurement.
- Assessed EGFR expression via indirect immunofluorescence flow cytometry.
- Employed FITC-EGF binding and internalization flow cytometry to analyze receptor activity.
Main Results:
- IFN-alpha upregulated cell surface EGFR in 70% of colon cancer cell lines within 16-96 hours.
- IFN-alpha treatment led to transient intracellular EGFR elevation and significant growth inhibition.
- Colon cancer cells pretreated with IFN-alpha remained sensitive to EGF-induced proliferation.
Conclusions:
- Cytostatic IFN-alpha concentrations enhance both cell surface and intracellular EGFR expression in a subset of colon cancer cells.
- The antiproliferative effect of IFN-alpha does not inhibit EGF-EGFR pathway signal transduction.
- Findings suggest potential clinical applications for IFN-alpha in combination with EGFR-targeted therapies.
Related Concept Videos
02:38Mitogens and the Cell Cycle
01:15Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:24Regulation of Angiogenesis and Blood Supply
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal